GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Pre-Tax Income

Ipca Laboratories (BOM:524494) Pre-Tax Income : ₹8,955 Mil (TTM As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Ipca Laboratories's pretax income for the three months ended in Dec. 2023 was ₹2,889 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was ₹8,955 Mil. Ipca Laboratories's pretax margin was 14.07%.

During the past 13 years, Ipca Laboratories's highest Pretax Margin was 25.88%. The lowest was 4.07%. And the median was 13.41%.


Ipca Laboratories Pre-Tax Income Historical Data

The historical data trend for Ipca Laboratories's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Pre-Tax Income Chart

Ipca Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,464.60 7,388.90 13,889.80 11,357.20 7,452.90

Ipca Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,693.40 1,294.40 2,518.20 2,253.60 2,888.90

Competitive Comparison of Ipca Laboratories's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ipca Laboratories's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Ipca Laboratories's Pre-Tax Income falls into.



Ipca Laboratories Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Ipca Laboratories's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=7047.6+0+-450.9+793.5+62.699999999999
=7,453

Ipca Laboratories's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=2318.3+0+-334+0+904.6
=2,889

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8,955 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ipca Laboratories  (BOM:524494) Pre-Tax Income Explanation

Ipca Laboratories's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=2888.9/20528.6
=14.07%

During the past 13 years, Ipca Laboratories's highest Pretax Margin was 25.88%. The lowest was 4.07%. And the median was 13.41%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ipca Laboratories Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipca Laboratories (BOM:524494) Business Description

Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (BOM:524494) Headlines

No Headlines